drug
as of 2026-07-01Customized Adherence Enhancement for Schizophrenia (CAE-S)
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by University Hospitals Cleveland Medical Center
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
BEHAVIORAL
Indications
Investigational (via trials)
Trials
1
CAE for Poorly Adherent Individuals With Schizophrenia
NCT06061952—Completed
KOLs & investigators
1
Martha Sajatovic, MDKOL score 7
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here